BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

357 related articles for article (PubMed ID: 30257373)

  • 1. DIXDC1 promotes the growth of acute myeloid leukemia cells by upregulating the Wnt/β-catenin signaling pathway.
    Xin H; Li C; Wang M
    Biomed Pharmacother; 2018 Nov; 107():1548-1555. PubMed ID: 30257373
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Suppression of Disheveled-Axin Domain Containing 1 (DIXDC1) by MicroRNA-186 Inhibits the Proliferation and Invasion of Retinoblastoma Cells.
    Che X; Qian Y; Li D
    J Mol Neurosci; 2018 Feb; 64(2):252-261. PubMed ID: 29264763
    [TBL] [Abstract][Full Text] [Related]  

  • 3. TRIM31 promotes acute myeloid leukemia progression and sensitivity to daunorubicin through the Wnt/β-catenin signaling.
    Xiao Y; Deng T; Ming X; Xu J
    Biosci Rep; 2020 Apr; 40(4):. PubMed ID: 32232394
    [TBL] [Abstract][Full Text] [Related]  

  • 4. DIXDC1 prevents oxygen-glucose deprivation/reoxygenation-induced injury in hippocampal neurons in vitro by promoting Wnt/β-catenin signaling.
    Li T; Wan YC; Sun LJ; Tao SJ; Chen P; Liu CH; Wang K; Zhou CY; Zhao GQ
    Eur Rev Med Pharmacol Sci; 2018 Sep; 22(17):5678-5687. PubMed ID: 30229845
    [TBL] [Abstract][Full Text] [Related]  

  • 5. DIXDC1 targets p21 and cyclin D1 via PI3K pathway activation to promote colon cancer cell proliferation.
    Wang L; Cao XX; Chen Q; Zhu TF; Zhu HG; Zheng L
    Cancer Sci; 2009 Oct; 100(10):1801-8. PubMed ID: 19572978
    [TBL] [Abstract][Full Text] [Related]  

  • 6. LncRNA SNHG1 contributes to the regulation of acute myeloid leukemia cell growth by modulating miR-489-3p/SOX12/Wnt/β-catenin signaling.
    Li C; Gao Q; Wang M; Xin H
    J Cell Physiol; 2021 Jan; 236(1):653-663. PubMed ID: 32592199
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Overexpression of DIXDC1 correlates with enhanced cell growth and poor prognosis in human pancreatic ductal adenocarcinoma.
    Li X; Xiao Y; Fan S; Xiao M; Wang X; Zhu X; Chen X; Li C; Zong G; Zhou G; Wan C
    Hum Pathol; 2016 Nov; 57():182-192. PubMed ID: 27498060
    [TBL] [Abstract][Full Text] [Related]  

  • 8. LRRC1 knockdown downregulates MACF1 to inhibit the malignant progression of acute myeloid leukemia by inactivating β-catenin/c-Myc signaling.
    Wang Y; Tong H; Wang J; Hu L; Huang Z
    J Mol Histol; 2024 Feb; 55(1):37-50. PubMed ID: 38165568
    [TBL] [Abstract][Full Text] [Related]  

  • 9. DIXDC1 activates the Wnt signaling pathway and promotes gastric cancer cell invasion and metastasis.
    Tan C; Qiao F; Wei P; Chi Y; Wang W; Ni S; Wang Q; Chen T; Sheng W; Du X; Wang L
    Mol Carcinog; 2016 Apr; 55(4):397-408. PubMed ID: 25648220
    [TBL] [Abstract][Full Text] [Related]  

  • 10. MicroRNA-539 inhibits glioma cell proliferation and invasion by targeting DIXDC1.
    Quan J; Qu J; Zhou L
    Biomed Pharmacother; 2017 Sep; 93():746-753. PubMed ID: 28704799
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Disruption of Wnt/β-Catenin Exerts Antileukemia Activity and Synergizes with FLT3 Inhibition in
    Jiang X; Mak PY; Mu H; Tao W; Mak DH; Kornblau S; Zhang Q; Ruvolo P; Burks JK; Zhang W; McQueen T; Pan R; Zhou H; Konopleva M; Cortes J; Liu Q; Andreeff M; Carter BZ
    Clin Cancer Res; 2018 May; 24(10):2417-2429. PubMed ID: 29463558
    [No Abstract]   [Full Text] [Related]  

  • 12. HOTAIRM1 knockdown enhances cytarabine-induced cytotoxicity by suppression of glycolysis through the Wnt/β-catenin/PFKP pathway in acute myeloid leukemia cells.
    Chen L; Hu N; Wang C; Zhao H
    Arch Biochem Biophys; 2020 Feb; 680():108244. PubMed ID: 31904363
    [TBL] [Abstract][Full Text] [Related]  

  • 13. SOX30 confers a tumor suppressive effect in acute myeloid leukemia through inactivation of Wnt/β-catenin signaling.
    Liu Y; Wang W; Li Y; Huang Y
    Mol Cell Probes; 2020 Aug; 52():101578. PubMed ID: 32334007
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Deptor Is a Novel Target of Wnt/β-Catenin/c-Myc and Contributes to Colorectal Cancer Cell Growth.
    Wang Q; Zhou Y; Rychahou P; Harris JW; Zaytseva YY; Liu J; Wang C; Weiss HL; Liu C; Lee EY; Evers BM
    Cancer Res; 2018 Jun; 78(12):3163-3175. PubMed ID: 29666061
    [TBL] [Abstract][Full Text] [Related]  

  • 15. LncRNA-DUXAP8 Regulation of the Wnt/β-Catenin Signaling Pathway to Inhibit Glycolysis and Induced Apoptosis in Acute Myeloid Leukemia.
    Zhai H; Zhao J; Pu J; Zhao P; Wei J
    Turk J Haematol; 2021 Dec; 38(4):264-272. PubMed ID: 34431643
    [TBL] [Abstract][Full Text] [Related]  

  • 16. High expression of long intergenic non-coding RNA LINC00662 contributes to malignant growth of acute myeloid leukemia cells by upregulating ROCK1 via sponging microRNA-340-5p.
    Liu Y; Gao X; Tian X
    Eur J Pharmacol; 2019 Sep; 859():172535. PubMed ID: 31306637
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Non-canonical activation of β-catenin by PRL-3 phosphatase in acute myeloid leukemia.
    Chong PSY; Zhou J; Chooi JY; Chan ZL; Toh SHM; Tan TZ; Wee S; Gunaratne J; Zeng Q; Chng WJ
    Oncogene; 2019 Feb; 38(9):1508-1519. PubMed ID: 30305722
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Knockdown of TRIM24 suppresses growth and induces apoptosis in acute myeloid leukemia through downregulation of Wnt/GSK-3β/β-catenin signaling.
    Li C; Xin H; Shi Y; Mu J
    Hum Exp Toxicol; 2020 Dec; 39(12):1725-1736. PubMed ID: 32672070
    [TBL] [Abstract][Full Text] [Related]  

  • 19. MiRNA-301b-3p induces proliferation and inhibits apoptosis in AML cells by targeting FOXF2 and regulating Wnt/β-catenin axis.
    Lu Y; Zhong L; Luo X; Liu C; Dan W; Chu X; Wan P; Zhang Z; Wang X; Liu Z; Liu B
    Mol Cell Probes; 2022 Jun; 63():101805. PubMed ID: 35259424
    [TBL] [Abstract][Full Text] [Related]  

  • 20. LncRNA SNHG20 enhances the progression of oral squamous cell carcinoma by regulating the miR-29a/DIXDC1/Wnt regulatory axis.
    Chen ZF; Wang Y; Sun LL; Ding SY; Jinag H
    Eur Rev Med Pharmacol Sci; 2020 May; 24(10):5436-5445. PubMed ID: 32495922
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.